Skip to main content

Balancing the benefits and risks of inhaled long-acting beta-agonists--the influence of values.

Publication ,  Journal Article
Kramer, JM
Published in: N Engl J Med
April 16, 2009

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

N Engl J Med

DOI

EISSN

1533-4406

Publication Date

April 16, 2009

Volume

360

Issue

16

Start / End Page

1592 / 1595

Location

United States

Related Subject Headings

  • United States Food and Drug Administration
  • United States
  • Risk Assessment
  • Humans
  • General & Internal Medicine
  • Drug Labeling
  • Drug Approval
  • Delayed-Action Preparations
  • Bronchodilator Agents
  • Asthma
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kramer, J. M. (2009). Balancing the benefits and risks of inhaled long-acting beta-agonists--the influence of values. N Engl J Med, 360(16), 1592–1595. https://doi.org/10.1056/NEJMp0810561
Kramer, Judith M. “Balancing the benefits and risks of inhaled long-acting beta-agonists--the influence of values.N Engl J Med 360, no. 16 (April 16, 2009): 1592–95. https://doi.org/10.1056/NEJMp0810561.
Kramer, Judith M. “Balancing the benefits and risks of inhaled long-acting beta-agonists--the influence of values.N Engl J Med, vol. 360, no. 16, Apr. 2009, pp. 1592–95. Pubmed, doi:10.1056/NEJMp0810561.

Published In

N Engl J Med

DOI

EISSN

1533-4406

Publication Date

April 16, 2009

Volume

360

Issue

16

Start / End Page

1592 / 1595

Location

United States

Related Subject Headings

  • United States Food and Drug Administration
  • United States
  • Risk Assessment
  • Humans
  • General & Internal Medicine
  • Drug Labeling
  • Drug Approval
  • Delayed-Action Preparations
  • Bronchodilator Agents
  • Asthma